-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Group’s Bosheng Medical Devices Has Been Recognized as a “Specialized, Refined, Distinctive, and Innovative” Small and Medium-Sized Enterprise in Jiangsu Province.
Category:
发布时间：2022-12-13
【概要描述】
Recently, the Jiangsu Provincial Department of Industry and Information Technology released the list of the first batch of “specialized, refined, distinctive, and innovative” small and medium-sized enterprises in Jiangsu Province for 2022, as well as the list of enterprises that passed the re-examination. Shijiazhuang Sihua Pharmaceutical Group’s Jiangsu Bosheng Medical New Materials Co., Ltd. was recognized as a “specialized, refined, distinctive, and innovative” SME in Jiangsu Province.
Recently, the Jiangsu Provincial Department of Industry and Information Technology released the list of 2022 Jiangsu Province “Specialized, Refined, Distinctive, and Innovative” SMEs (first batch) and the list of enterprises that passed the re-examination. Shijiazhuang Sihua Pharmaceutical Group’s Jiangsu Bosheng Medical New Materials Co., Ltd. was recognized as a Jiangsu Province “Specialized, Refined, Distinctive, and Innovative” SME.
According to reports, “specialized, refined, distinctive, and innovative” enterprises are those that embody the four core characteristics of specialization, refinement, distinctiveness, and innovation. They set the direction for development in their respective niche industries in terms of products, technologies, business models, and operational approaches; boast high levels of technological sophistication and management excellence; demonstrate strong growth potential and substantial development prospects; serve as a critical pillar of future industrial chains; act as a dynamic force in strengthening and complementing these chains; and play a vital role in driving high-quality economic and social development.
Shijiazhuang Sihua Pharmaceutical Group Bosun Medical Materials is a high-tech enterprise specializing in the production and R&D of pharmaceutical stoppers and gaskets, multilayer co-extruded medical films, and multilayer cast biofilms. With more than two decades of dedicated expertise in the manufacturing of cutting-edge, high-precision medical packaging materials, Bosun Medical Materials has consistently pursued a development strategy characterized by specialization, refinement, distinctiveness, and innovation. The company remains firmly focused on its core business, champions independent innovation, and has established an efficient, state-of-the-art R&D system for pharmaceutical packaging materials. It has independently developed a series of premium formulations and advanced processing technologies, including, domestically, pioneering proprietary vacuum deposition technology for poly(p-xylene) coatings, novel formulations and processes for cephalosporin-specific stoppers, and the successful launch of a family of coated stopper products that fill critical domestic gaps. Moreover, Bosun is the only domestic manufacturer to master the production technology for radiation-resistant sterilizable stoppers. In addition, the company was the first in China to develop multilayer co-extruded biofilms for single-use systems, whose overall performance rivals that of imported competitors, thereby providing domestic pharmaceutical companies with an optimal option for domestic substitution. By actively exploring new technologies and innovative concepts in the field of pharmaceutical packaging, Bosun Medical Materials continues to demonstrate robust innovation and strong growth resilience, emerging as a key driver of technological advancement and industrial development in the pharmaceutical packaging sector.
A representative from Bosheng Medical Devices stated that the company will take its recent designation as a provincial “Specialized, Refined, Distinctive, and Innovative” SME as an opportunity to continuously increase investment in scientific and technological innovation, strengthen efforts to develop cutting-edge core technologies, fully leverage the exemplary role of “specialized, refined, distinctive, and innovative” enterprises, strive to be a frontrunner in economic transformation and upgrading and a mainstay of innovation-driven development, and lead the advancement of the industry.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091